web analytics
5.4 C
Munich
Tuesday, November 29, 2022

Stock in Focus: GREENHOUSE SOLUTIONS (OTCMKTS:GRSU)

GREENHOUSE SOLUTIONS (OTCMKTS:GRSU) has been moving up steadily in recent days off its base at $0.40 to recent highs over $0.60. The stock has transformed in recent days from illiquid to some big volume doing several hundred thousand shares a day.

GRSU sure looks like promo; there are paid guys posting on IHUB and it seems to be working so far as GRSU volume and price have popped significantly.

GREENHOUSE SOLUTIONS (OTCMKTS:GRSU) operates three distinct business units within the burgeoning cannabis market: Greenhouse Solutions’ Design & Consulting Service offers an all-inclusive solution to the expansion and efficiency of hydroponic and agricultural businesses nationwide.

The Company is able to supply a comprehensive solution to the design, build, implementation, production, and expansion of all variations of indoor, outdoor and greenhouse agricultural business; Greenhouse Solutions’ Product Development develops, markets, produces and sells cannabidiol (“CBD”) products for both the personal health and companion pet markets utilizing a licensed probiotic delivery system (US Patent #6,080,401) and other licensed formulas.

Cannabidiol (CBD) is a naturally-occurring substance found in both the cannabis and hemp species of the Cannabis Sativa plant; and Growhouse Solutions acts as a distributor for a variety of equipment, supplies and nutrients for the growhouse industry.

On February 25 GRSU announced their plans to manufacture, market and sell a proprietary product for the alleviation of pain in companion animals utilizing Cannabidiols (CBDs) and Probiotics. Greenhouse Solutions previously announced that they were creating products for both the personal health and companion pet markets utilizing a licensed probiotic delivery system (US Patent #6,080,401). Today’s announcement marks the first product to be developed in the Company’s new division that takes advantage of new research in CBD.

To Find out the inside Scoop on GRSU  Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

According to The American Pet Products Association (APPA) there are 83 million dogs and 95 million cats in the US. These companion animals are as susceptible as humans to ailments that require pain-relieving solutions. The total market for companion animals in the US reached an estimated $58.5 billion in 2014. Of these expenditures, over $13 billion was spent on medication for the animals. Additionally, a 2009 survey conducted by Virbac Pharmaceuticals puts the annual US market for companion animal pain relievers at more than $250 million.

CEO Rik J Deitsch said “I have been working with Dr. Reddy to formulate products that utilize the best aspects of the new research and licensed technologies. I’m very excited to get this first product underway as we create new paradigms with the use of Cannabidiols and probiotics for the wellness marketplace,” he continued. “We know that the pain market in companion animals is large and mostly unmet. This will be a necessary product that will make a real difference for millions of pets,” he concluded.

According to Mr. Deitsch the only person that can perceive the pain of the pet is the pet owner. Due to severe pain, the dogs and cats do not eat properly , do not rest and thus develop other serious complications such as, constipation, pruritis (severe itching of the anal area) and restlessness etc,”

He concluded “This all natural patented approach of Green House Solutions using Cannabidiols (CBDs) and species specific Probiotics will alleviate the pain thru the synbiosis. In this particular preparation, Probiotics not only help the activation of the Cannabidiols to enhance the pain relieving property (even at a small dose) but also improve the overall Gastro Intestinal Health of the animals. These all natural products of Green House Solutions does not give any serious side effects (unlike the other Allopathic medicines), which will hurt the health of the companion animals.”

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $45 million market valuation GRSU has no assets or revenues and rising debt. The Company does operate in the red hot Cannabis space and has been putting out some big press in recent days. We will be updating GRSU as events unfold so make sure you are subscribed to Microcapdaily so you know what is going on with GRSU.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in GRSU either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.